Influx Healthtech Limited, a digital-first healthcare and wellness services provider, has recorded a strong Day 2 performance in its ongoing Initial Public Offering (IPO). The issue has seen a total subscription of 16 times, led by high demand from both retail and non-institutional investors. Additionally, the Grey Market Premium (GMP) is steady at 47 percent, signaling positive listing expectations when the stock hits the NSE SME platform.

The IPO, which opened on June 19, 2025, will close on June 21, 2025. The allotment is expected by June 24, and the stock is tentatively scheduled to list on June 26, 2025.

Day 2 Subscription Status

The IPO has gained strong traction, particularly in the retail and HNI categories. The Day 2 subscription figures are as follows:

• Retail Individual Investors (RIIs): 21.8x

• Non-Institutional Investors (NIIs): 13.4x

• Qualified Institutional Buyers (QIBs): 3.2x

• Overall Subscription: 16.01x

With one day remaining, analysts expect the issue to close with massive oversubscription, potentially crossing 25x–30x by Day 3, given the current pace.

Grey Market Premium (GMP) Update

The Grey Market Premium is hovering around 47 percent, translating to an estimated listing price of ₹132 to ₹135 against the upper price band of ₹92.

The strong GMP suggests robust pre-listing demand and investor belief in the company’s growth story and sector prospects. The steady GMP trend over the past two days has further cemented expectations of a premium listing on debut.

Company Overview

Influx Healthtech Limited is a tech-enabled wellness and preventive healthcare platform offering:

• Digital diagnostics and pathology services

• AI-powered health risk assessments

• Personalised telemedicine and virtual care solutions

• Health management for corporates and insurance partners

The company operates a hybrid model, combining digital health tools with physical wellness centers, targeting urban millennials, working professionals, and lifestyle disease patients.

Its tech integrations and partnerships with healthcare practitioners make it one of the emerging players in India’s digital health landscape.

IPO Details

• IPO Price Band: ₹90 to ₹92 per equity share

• Issue Size: ₹19.65 crore (entirely fresh issue)

• Lot Size: 1,200 shares

• Minimum Retail Investment: ₹1,10,400

• Listing Platform: NSE SME

• Lead Manager: Gretex Corporate Services Limited

• Registrar: Bigshare Services Pvt. Ltd.

• Market Maker: Nikunj Stock Brokers

Financial Performance Snapshot

Influx Healthtech’s financial performance has improved steadily in the last three years:

• Revenue (FY24): ₹16.8 crore

• EBITDA (FY24): ₹3.2 crore

• Profit After Tax (FY24): ₹2.3 crore

• ROCE: 20.4%

• ROE: 18.9%

• Post-issue P/E Ratio: 13.9x

• Industry Average P/E: 20x+

The reasonable valuation, paired with high-growth potential in India’s digital health sector, has made this IPO attractive to both retail and HNI segments.

Use of IPO Proceeds

The proceeds from the IPO will be utilized for:

• Technology enhancement and app development

• Marketing and user acquisition

• Setting up new wellness hubs in metro cities

• Working capital and general corporate purposes

The company aims to strengthen its digital infrastructure, broaden its healthcare delivery footprint, and scale operations across multiple states.

Expert Views

Market analysts have shared positive sentiments about the IPO due to the following factors:

• Exposure to the booming health-tech segment

• Early mover advantage in AI-driven diagnostics and virtual care

• Reasonable pricing and strong demand across investor categories

• Robust GMP holding steady despite market volatility

However, experts also advise caution due to competitive risks, including larger health-tech platforms and regulatory uncertainties in digital healthcare.

Conclusion

With a 16x subscription by Day 2 and a GMP of 47 percent, the Influx Healthtech IPO has emerged as one of the more sought-after SME issues in June 2025. Strong fundamentals, sectoral relevance, and a scalable business model have attracted investors across categories.

The final day subscription figures and listing performance will be closely watched, especially by those eyeing short-term gains and long-term exposure to health-tech innovation.

Recommendation: Positive outlook for listing gain and long-term growth. Investors may apply after evaluating personal risk appetite.

Disclaimer:
This article is for educational and informational purposes only and does not constitute financial advice. Investment decisions should be based on individual risk tolerance and consultation with SEBI-registered advisors. Market conditions are volatile and subject to change. Neither the author nor the platform is responsible for losses arising from use of this information.

The Upcoming IPOs in this week and coming weeks are Abram Food, PRO FX Tech, Suntech Infra Solutions, Shri Hare-Krishna Sponge Iron, Icon Facilitators, Ace Alpha Tech, Globe Civil Projects, Sambhav Steel Tubes, Ellenbarrie Indutrial Gases, Kalpataru, HDB Financials, AJC Jewel.

The Current active IPO are  Aakaar Medical Technologies, Safe Enterprises Retail Fixtures, Mayasheel Ventures, ArisInfra Solutions, Influx Healthtech.

Start your Stock Market Journey and Apply in IPO by Opening Free Demat Account in Choice Broking FinX.

Join our Trading with CA Abhay Telegram Channel for regular Stock Market Trading and Investment Calls by CA Abhay Varn - SEBI Registered Research Analyst.